Literature DB >> 27184752

HPV Update: Vaccination, Screening, and Associated Disease.

Megan McNamara1, Pelin Batur2, Judith M E Walsh3, Kay M Johnson4.   

Abstract

Human papillomavirus (HPV) infection is the causative agent in cervical cancer, and is associated with numerous other genital cancers, including vulvar, vaginal, and anal cancer. Primary prevention with HPV vaccination is safe and efficacious, and a recently approved HPV vaccine will provide even more extensive protection against several oncogenic HPV strains. Screening strategies for HPV are rapidly evolving, reflecting the essential role that HPV infection plays in cervical cancer. This article highlights new evidence regarding the efficacy of the recently approved 9-valent HPV (9vHPV) vaccine and the use of primary high-risk HPV testing in cervical cancer screening. We consider the utility of urinary HPV testing in routine clinical practice and review current guidelines regarding anal HPV screening.

Entities:  

Keywords:  HPV; cervical cancer; prevention; screening; vaccination

Mesh:

Substances:

Year:  2016        PMID: 27184752      PMCID: PMC5071275          DOI: 10.1007/s11606-016-3725-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  29 in total

1.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

2.  Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States.

Authors:  Marc Brisson; Jean-François Laprise; Harrell W Chesson; Mélanie Drolet; Talía Malagón; Marie-Claude Boily; Lauri E Markowitz
Journal:  J Natl Cancer Inst       Date:  2015-10-04       Impact factor: 13.506

3.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors:  Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

4.  Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

Authors:  Thomas C Wright; Mark H Stoler; Catherine M Behrens; Abha Sharma; Guili Zhang; Teresa L Wright
Journal:  Gynecol Oncol       Date:  2015-01-08       Impact factor: 5.482

5.  Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.

Authors:  Hammad Ali; Basil Donovan; Handan Wand; Tim R H Read; David G Regan; Andrew E Grulich; Christopher K Fairley; Rebecca J Guy
Journal:  BMJ       Date:  2013-04-18

6.  Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.

Authors:  Hugo De Vuyst; Gary M Clifford; Maria Claudia Nascimento; Margaret M Madeleine; Silvia Franceschi
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

7.  Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study.

Authors:  Yurii B Shvetsov; Brenda Y Hernandez; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Marc T Goodman
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

Review 8.  Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis.

Authors:  Neha Pathak; Julie Dodds; Javier Zamora; Khalid Khan
Journal:  BMJ       Date:  2014-09-16

9.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.

Authors:  Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-31       Impact factor: 17.586

10.  Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

Authors:  Guglielmo Ronco; Joakim Dillner; K Miriam Elfström; Sara Tunesi; Peter J F Snijders; Marc Arbyn; Henry Kitchener; Nereo Segnan; Clare Gilham; Paolo Giorgi-Rossi; Johannes Berkhof; Julian Peto; Chris J L M Meijer
Journal:  Lancet       Date:  2013-11-03       Impact factor: 79.321

View more
  8 in total

Review 1.  Pediatric Gynecologic Cancers.

Authors:  Lauren Pommert; William Bradley
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

2.  Misinformation, Gendered Perceptions, and Low Healthcare Provider Communication Around HPV and the HPV Vaccine Among Young Sexual Minority Men in New York City: The P18 Cohort Study.

Authors:  Jessica Jaiswal; Caleb LoSchiavo; Anthony Maiolatesi; Farzana Kapadia; Perry N Halkitis
Journal:  J Community Health       Date:  2020-08

Review 3.  Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plants.

Authors:  Anuradha Sehrawat; Ruchi Roy; Subrata K Pore; Eun-Ryeong Hahm; Suman K Samanta; Krishna B Singh; Su-Hyeong Kim; Kamayani Singh; Shivendra V Singh
Journal:  Semin Cancer Biol       Date:  2016-11-17       Impact factor: 15.707

4.  Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center.

Authors:  Kaan Z Apaydin; Holly B Fontenot; Derri L Shtasel; Kenneth H Mayer; Alex S Keuroghlian
Journal:  J Community Health       Date:  2018-08

Review 5.  Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.

Authors:  Arnaud John Kombe Kombe; Bofeng Li; Ayesha Zahid; Hylemariam Mihiretie Mengist; Guy-Armel Bounda; Ying Zhou; Tengchuan Jin
Journal:  Front Public Health       Date:  2021-01-20

Review 6.  Cancer Prevention by Natural Products Introduced into the Diet-Selected Cyclitols.

Authors:  Karol Wiśniewski; Marcin Jozwik; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 7.  Maternal HPV Infection: Effects on Pregnancy Outcome.

Authors:  Carmen Elena Condrat; Lidia Filip; Mirela Gherghe; Dragos Cretoiu; Nicolae Suciu
Journal:  Viruses       Date:  2021-12-07       Impact factor: 5.048

Review 8.  Current update on vaginal malignancies.

Authors:  Rachel Stein; Dhakshinamoorthy Ganeshan; Dheeraj Reddy Gopireddy; Ammar Chaudhry; Sindhu Kumar; Karthik Bande; Priya Bhosale; Chandana Lall
Journal:  Abdom Radiol (NY)       Date:  2021-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.